The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Janeczek, Agnieszka Aleksandra, Dr
    General Manager born in April 1987
    Individual (1 offspring)
    Officer
    2022-09-01 ~ now
    OF - Director → CIF 0
  • 2
    Oreffo, Richard, Prof
    Scientist born in September 1961
    Individual (1 offspring)
    Officer
    2017-03-22 ~ now
    OF - Director → CIF 0
  • 3
    Otter, James Anthony
    Director born in November 1957
    Individual (10 offsprings)
    Officer
    2017-03-22 ~ now
    OF - Director → CIF 0
  • 4
    Ferrara, Lisa Anne
    Company Director born in November 1963
    Individual (1 offspring)
    Officer
    2024-08-15 ~ now
    OF - Director → CIF 0
Ceased 7
  • 1
    Prof Richard Oreffo
    Born in September 1961
    Individual (1 offspring)
    Person with significant control
    2017-03-22 ~ 2017-10-31
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Otter James
    Born in November 1957
    Individual (10 offsprings)
    Person with significant control
    2017-03-22 ~ 2017-10-20
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    Sinclair, Simon, Dr
    Director born in May 1972
    Individual (2 offsprings)
    Officer
    2019-04-17 ~ 2024-08-15
    OF - Director → CIF 0
  • 4
    Harris, Michael
    Ceo born in May 1970
    Individual
    Officer
    2023-06-26 ~ 2025-03-07
    OF - Director → CIF 0
  • 5
    Smith, Peter John Shand, Professor
    Academic born in June 1954
    Individual
    Officer
    2017-12-19 ~ 2019-04-17
    OF - Director → CIF 0
  • 6
    Jonathan Dawson
    Born in March 1981
    Individual (1 offspring)
    Person with significant control
    2017-03-22 ~ 2017-10-31
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 7
    Building 37 Finance Department, University Of Southampton, Highfield, Southampton, Hampshire, England
    Active Corporate (5 parents, 1 offspring)
    Person with significant control
    2017-10-31 ~ 2023-06-26
    PE - Has significant influence or control → CIF 0
parent relation
Company in focus

RENOVOS BIOLOGICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
62023-04-01 ~ 2024-03-31
42022-04-01 ~ 2023-03-31
Intangible Assets
7,085 GBP2024-03-31
8,502 GBP2023-03-31
Property, Plant & Equipment
1,885 GBP2024-03-31
3,896 GBP2023-03-31
Fixed Assets
8,970 GBP2024-03-31
12,398 GBP2023-03-31
Debtors
Current
39,021 GBP2024-03-31
45,115 GBP2023-03-31
Cash at bank and in hand
646,676 GBP2024-03-31
15,828 GBP2023-03-31
Current Assets
685,697 GBP2024-03-31
60,943 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
-15,612 GBP2024-03-31
-13,780 GBP2023-03-31
Net Current Assets/Liabilities
670,085 GBP2024-03-31
47,163 GBP2023-03-31
Net Assets/Liabilities
679,055 GBP2024-03-31
59,561 GBP2023-03-31
Equity
Called up share capital
37 GBP2024-03-31
28 GBP2023-03-31
Share premium
1,492,918 GBP2024-03-31
728,603 GBP2023-03-31
Retained earnings (accumulated losses)
-813,900 GBP2024-03-31
-669,070 GBP2023-03-31
Equity
679,055 GBP2024-03-31
59,561 GBP2023-03-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
202023-04-01 ~ 2024-03-31
Computers
202023-04-01 ~ 2024-03-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
14,170 GBP2024-03-31
14,170 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
7,085 GBP2024-03-31
5,668 GBP2023-03-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
7,085 GBP2024-03-31
8,502 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
53,655 GBP2024-03-31
53,655 GBP2023-03-31
Computers
2,786 GBP2024-03-31
776 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
56,441 GBP2024-03-31
54,431 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
49,818 GBP2023-03-31
Computers
717 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
50,535 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
3,837 GBP2023-04-01 ~ 2024-03-31
Computers, Owned/Freehold
184 GBP2023-04-01 ~ 2024-03-31
Owned/Freehold
4,021 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
53,655 GBP2024-03-31
Computers
901 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
54,556 GBP2024-03-31
Property, Plant & Equipment
Computers
1,885 GBP2024-03-31
59 GBP2023-03-31
Plant and equipment
3,837 GBP2023-03-31
Other Debtors
Current
9,815 GBP2024-03-31
6,113 GBP2023-03-31
Prepayments/Accrued Income
Current
5,999 GBP2023-03-31
Amount of corporation tax that is recoverable
Current
29,206 GBP2024-03-31
33,003 GBP2023-03-31
Trade Creditors/Trade Payables
Current
750 GBP2024-03-31
6,040 GBP2023-03-31
Taxation/Social Security Payable
Current
7,153 GBP2024-03-31
2,971 GBP2023-03-31
Other Creditors
Current
2,709 GBP2024-03-31
769 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
5,000 GBP2024-03-31
4,000 GBP2023-03-31
Creditors
Current
15,612 GBP2024-03-31
13,780 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
368,072 shares2024-03-31
284,448 shares2023-03-31
Par Value of Share
Class 1 ordinary share
0.00012023-04-01 ~ 2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
983 GBP2024-03-31
5,896 GBP2023-03-31
Between one and five year
983 GBP2023-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
983 GBP2024-03-31
6,879 GBP2023-03-31
  • RENOVOS BIOLOGICS LIMITED
    Info
    Registered number 10685524
    2 Venture Road Southampton Science Park, Chilworth, Southampton SO16 7NP
    Private Limited Company incorporated on 2017-03-22 (8 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.